Envision Healthcare guidance likely conservative, says RBC Capital RBC Capital believes that Envision reported solid Q1 results. The firm thinks the company's guidance will prove to be conservative because it doesn't include benefits from health care reform. The firm keeps a $38 price target and Outperform rating on the shares.
News For EVHC From The Last 14 Days
Check below for free stories on EVHC the last two weeks.